Doug Hampton 
BOSTON, Sept. 26, 2023 /PRNewswire/ — Clinical trials utilizing RNAi drug delivery have surged, and BCC Research’s new report “RNAi Drug Delivery: Technologies and Global Markets” predicts just how much the market will grow. Did you know that this year, 2023, marks the 25th anniversary of RNAi’s discovery? Clinical RNAi diagnostic tools and therapies are revolutionizing … Read more
Agreement enables the development of therapeutics, including AcuraStem‘s AS-202 Candidate, an antisense oligonucleotide that suppresses levels of the PIKFYVE kinase MONROVIA, Calif., Sept. 25, 2023 /PRNewswire/ — AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that it has entered into a license agreement with Takeda to develop and commercialize … Read more
NEW YORK, Sept. 24, 2023 /PRNewswire/ — The Medical Active Air Sampling System Market size is expected to grow by USD 109.11 million, accelerating at a CAGR of 6.28% during the forecast period. Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position. The report also … Read more
—– YL201 Phase I/II Investigators Meeting was successfully held in Guangzhou, China GUANGZHOU, China, Sept. 23, 2023 /PRNewswire/ — On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the YL201 Phase I/II Investigators Meeting hosted by Suzhou MediLink Therapeutics Co., Ltd. The chair … Read more
SHANGHAI, Sept. 22, 2023 /PRNewswire/ — Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with drugs containing fluorouracil and platinum for the first-line treatment of patients with PD-L1 positive unresectable locally advanced/recurrent … Read more
New village embraces Life Time’s ethos for healthy living with 62,000-square-foot athletic club and outdoor amenity deck, along with 290 luxury residences available for lease STAMFORD, Conn., Sept. 22, 2023 /PRNewswire/ — Life Time (NYSE:LTH), the nation’s premier healthy lifestyle brand, today opened its first athletic country club in Connecticut with a nearly 52,000-square foot … Read more
LONDON, Sept. 21, 2023 /PRNewswire/ — Chlamydia Disease is one of the most prevalence sexually transmitted infections. As per a data released by NIH, nearly 4 million cases are registered ever year in US alone. Although it can affect both males and females, irrespective of their age groups, but young women are highly susceptible to this STI. … Read more
CHATTANOOGA, Tenn., Sept. 20, 2023 /PRNewswire/ — Unum Group (NYSE: UNM) will release its third quarter 2023 results October 31, 2023, at approximately 4:15 p.m. Eastern Standard Time. The earnings release and financial supplement will be available in the Investors section of the company’s website, which can be directly accessed at www.investors.unum.com. (PRNewsfoto/Unum Group) Members … Read more
SHANGHAI, Sept. 19, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing, manufacturing, and commercializing transformative pharmaceutical products and vaccines in Greater China and other parts of Asia, announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has recommended Priority Review for cefepime-taniborbactam … Read more
COPENHAGEN, Denmark , Sept. 19, 2023 /PRNewswire/ — HPNow, the pioneer in electrification of the hydrogen peroxide industry, announced the successful closing of a €14M round. The equity round is led by The Export and Investment Fund of Denmark (EIFO) together with Novo Holdings. Other investors in the round include MatiTech – a sustainable water treatment … Read more